Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Humana ABLTS:0RF7 +9.60%58 EV-to-OCF is 10.09 as of Aug. 20, 2026, which is 2% above its 10-year median of 9.94. GuruFocus rates LTS:0RF7 with a GF Score™ of 58/100 and a GF Value™ of kr37.16 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 682 Healthcare Providers & Services companies, Humana AB ranks worse than 53.81% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Humana AB's Enterprise Value is kr7,435 Mil.
Humana AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was kr737 Mil. Therefore, Humana AB's EV-to-OCF for today is 10.09.
The historical rank and industry rank for Humana AB's EV-to-OCF or its related term are showing as below:
LTS:0RF7'
s EV-to-OCF Range Over the Past 10 Years
Min: -38.46 Med: 9.94 Max: 28.73
Current: 9.67
During the past 13 years, the highest EV-to-OCF of Humana AB was 28.73. The lowest was -38.46. And the median was 9.94.
LTS:0RF7's EV-to-OCF is ranked worse than 53.81% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 8.775
vs LTS:0RF7: 9.67
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Humana AB's share price for today is kr69.65.
Humana AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3.540.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Humana AB EV-to-OCF Related Terms
Humana AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Humana AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Humana AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humana AB EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Humana AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Humana AB's EV-to-OCF falls into.
Humana AB's current Enterprise Value is kr7,435 Mil.
Humana AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr737 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humana AB (LTS:0RF7) has a EV-to-OCF of 10.09 as of Aug. 20, 2026. This is near median its historical median of 9.94. According to the industry distribution chart, Humana AB ranks #367 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 53.8%.
Is Humana AB's EV-to-OCF too high?
Humana AB's current EV-to-OCF of 10.09 is near median its 10-year median of 9.94. The Healthcare Providers & Services industry median EV-to-OCF is 8.78. Humana AB's value of 10.09 is 15% above this industry median. Based on the distribution chart, Humana AB ranks #367 out of 682 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Humana AB has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Humana AB's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Humana AB ranks #367 out of 682 companies for EV-to-OCF. This places Humana AB in the lower half of its industry. The industry median EV-to-OCF is 8.78. Humana AB's value of 10.09 is 15% above this benchmark. While the company's 10-year median is 9.94 vs. the industry median of 8.78, Humana AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.78, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humana AB's current EV-to-OCF of 10.09 is 15% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humana AB's current EV-to-OCF is 10.09, which is near median its own 10-year median of 9.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana AB stock overvalued right now?
Based on GuruFocus' analysis, Humana AB (LTS:0RF7) is currently considered Significantly Overvalued. The stock's GF Value™ is kr37.16, compared to a current price of kr69.65 — trading 87.4% above its estimated fair value. The current EV-to-OCF is 10.09, which is near median its 10-year median of 9.94 and 15% above the Healthcare Providers & Services industry median of 8.78. Humana AB's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Humana AB (LTS:0RF7), the current EV-to-OCF is 10.09 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humana AB (LTS:0RF7) Overvalued in 2026?
Based on GuruFocus' analysis, Humana AB stock appears to be overvalued.
The current stock price of kr69.65 is trading 87.4% above its estimated GF Value™ of kr37.16.
GuruFocus considers Humana AB to be Significantly Overvalued.
Key valuation signals for LTS:0RF7:
EV-to-OCF: 10.09 (near median its 10-year median of 9.94)
GF Value™: kr37.16 vs. price of kr69.65 (87.4% above fair value)
Industry Position: 15% above the Healthcare Providers & Services median (#367 of 682)
No single metric tells the full story. See the LTS:0RF7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humana AB is a provider of private care services in the Nordic region. The company offers services including individual and family care, personal assistance, elderly care and housing with special services. Geographically, the company operates in Sweden, Norway, Finland, Denmark, and others. It derives maximum revenue from Sweden.
58GF Score
Get the complete analysis for LTS:0RF7
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RF7 has been successfully added to your 
